BI-224436

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI-224436, covering 2012-02-09 to 2012-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Pharmacokinetics of Multiple Rising Oral Doses of BI 224436 in Healthy Male Volunteers. [Phase 1]